Travere Therapeutics (TVTX) Current Taxes (2015 - 2017)

Travere Therapeutics (TVTX) posted Current Taxes of $1.2 million for Q3 2017, down 70.3% on a QoQ basis from $3.9 million in Q3 2016, and down 70.3% year-over-year from $3.9 million in Q3 2016.

Travere Therapeutics (TVTX) Current Taxes (2015 - 2017) Analysis & Trends

Travere Therapeutics' Current Taxes history runs 3 years deep, the most recent figure standing at $1.2 million for Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Travere Therapeutics 5.21 Bn 5.21 Bn 125.25 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 1.15 Mn
Sep 30, 2016 3.88 Mn
Sep 30, 2015 9.63 Mn